Johnson & Johnson (JNJ) Business News

Track Johnson & Johnson in real time with a live news feed covering Johnson & Johnson stock news, official press releases, company announcements, and an archive of historical Johnson & Johnson news. ...more

  • Calendar
    Get instant access
    Sign up for free
    Month
    Jan
    Feb
    Mar
    Apr
    May
    Jun
    Jul
    Aug
    Sep
    Oct
    Nov
    Dec
    Date
    Su
    Mo
    Tu
    We
    Th
    Fr
    Sa
    Selected Filter
    No selection
3:35 PM | Thursday | Aug 27, 2026 ETF Trends

Bitcoin Powers Gains as Permanent Portfolio ETF Approaches $25M

News Thumbnail
2:38 PM | Thursday | Aug 27, 2026 247 Wallst

This $1.75 Million Portfolio Pays $10,200 a Month From Three Income Buckets

News Thumbnail
11:51 AM | Thursday | Aug 27, 2026 Zacks Investment Research

Oncology Stocks to Add to Your Portfolio as Cancer Care Evolves

News Thumbnail
5:42 AM | Thursday | Aug 27, 2026 Reuters

China approves J&J's oral psoriasis pill, says drugmaker

News Thumbnail
1:30 AM | Thursday | Aug 27, 2026 The Motley Fool

Johnson & Johnson Just Got a Big FDA Win

News Thumbnail
11:51 AM | Thursday | Aug 27, 2026 Zacks Investment Research

Oncology Stocks to Add to Your Portfolio as Cancer Care Evolves

News Thumbnail
5:42 AM | Thursday | Aug 27, 2026 Reuters

China approves J&J's oral psoriasis pill, says drugmaker

News Thumbnail
1:30 AM | Thursday | Aug 27, 2026 The Motley Fool

Johnson & Johnson Just Got a Big FDA Win

News Thumbnail
11:03 AM | Wednesday | Aug 26, 2026 247 Wallst

Dividends vs. an Annuity: Which Turns $840,000 Into More Monthly Income for Life?

News Thumbnail
8:57 AM | Wednesday | Aug 26, 2026 Fool - Investing News

Fidelity vs VanEck Healthcare ETFs: Broad Exposure or Pharma Focus

News Thumbnail
8:49 AM | Wednesday | Aug 26, 2026 247 Wallst

How Much Do You Need Invested by 55 to Retire on Dividends at 65?

News Thumbnail
7:00 AM | Wednesday | Aug 26, 2026 24/7 Wall Street

5 Blue-Chip Dividend Stocks to Buy Before August Ends

News Thumbnail
12:00 PM | Tuesday | Aug 25, 2026 24/7 Wall Street

Johnson & Johnson Is Near a Record High. Is There Still Room to Run?

News Thumbnail
9:25 AM | Tuesday | Aug 25, 2026 24/7 Wall Street

“Give Me Anything But Tech”: Jim Cramer's Bold Call on the Market's Next Big Rotation

News Thumbnail
8:02 AM | Tuesday | Aug 25, 2026 247 Wallst

How Much Do You Really Need Invested to Replace a $120,000 Salary With Dividends?

News Thumbnail

Bitcoin Powers Gains as Permanent Portfolio ETF Approaches $25M

ETF Trends

3:35 PM | Thursday | Aug 27, 2026

news photo
Loading...

Bitcoin exposure has powered early gains in the Porter & Company Porter Portfolio Index ETF (PCPP). The fund has grown to $23.9 million in assets less than three months after its launch, according to ETF Database data.

Read full article redirect
3:35 PM | Thursday | Aug 27, 2026

Bitcoin Powers Gains as Permanent Portfolio ETF Approaches $25M

ETF Trends

Bitcoin exposure has powered early gains in the Porter & Company Porter Portfolio Index ETF (PCPP). The fund has grown to $23.9 million in assets less than three months after its launch, according to ETF Database data.

Read full article arrow
News Thumbnail
2:38 PM | Thursday | Aug 27, 2026

This $1.75 Million Portfolio Pays $10,200 a Month From Three Income Buckets

247 Wallst

Chasing a 7% blended yield across a $1.75 million portfolio sounds straightforward until you realize that loading up on the highest payers quietly destroys the very income stream you built. Three buckets solve the problem in ways that a single fund simply cannot.

Read full article arrow
News Thumbnail
11:51 AM | Thursday | Aug 27, 2026

Oncology Stocks to Add to Your Portfolio as Cancer Care Evolves

Zacks Investment Research

Oncology innovation is driving new treatment options, with Iovance, Merit Medical and Kura advancing cancer-focused therapies and technologies.

Read full article arrow
News Thumbnail
5:42 AM | Thursday | Aug 27, 2026

China approves J&J's oral psoriasis pill, says drugmaker

Reuters

China's ​drug regulator has approved Johnson & Johnson's oral ‌pill for psoriasis, the company said on Thursday, intensifying competition in the world's second-largest pharmaceutical market ​with rivals including Bristol Myers Squibb and ​AbbVie.

Read full article arrow
News Thumbnail
1:30 AM | Thursday | Aug 27, 2026

Johnson & Johnson Just Got a Big FDA Win

The Motley Fool

Imaavy can be used to treat patients aged 12 and older with warm autoimmune hemolytic anemia (wAIHA), a rare blood disease. It's the second FDA win for JNJ in as many months.

Read full article arrow
News Thumbnail
11:51 AM | Thursday | Aug 27, 2026

Oncology Stocks to Add to Your Portfolio as Cancer Care Evolves

Zacks Investment Research

Oncology innovation is driving new treatment options, with Iovance, Merit Medical and Kura advancing cancer-focused therapies and technologies.

Read full article arrow
News Thumbnail
5:42 AM | Thursday | Aug 27, 2026

China approves J&J's oral psoriasis pill, says drugmaker

Reuters

China's ​drug regulator has approved Johnson & Johnson's oral ‌pill for psoriasis, the company said on Thursday, intensifying competition in the world's second-largest pharmaceutical market ​with rivals including Bristol Myers Squibb and ​AbbVie.

Read full article arrow
News Thumbnail
1:30 AM | Thursday | Aug 27, 2026

Johnson & Johnson Just Got a Big FDA Win

The Motley Fool

Imaavy can be used to treat patients aged 12 and older with warm autoimmune hemolytic anemia (wAIHA), a rare blood disease. It's the second FDA win for JNJ in as many months.

Read full article arrow
News Thumbnail
11:03 AM | Wednesday | Aug 26, 2026

Dividends vs. an Annuity: Which Turns $840,000 Into More Monthly Income for Life?

247 Wallst

A nest egg of $840,000 sits right at the crossroads where dividends and annuities each look surprisingly compelling, and where the wrong choice quietly costs you tens of thousands of dollars over a 20-year retirement.

Read full article arrow
News Thumbnail
8:57 AM | Wednesday | Aug 26, 2026

Fidelity vs VanEck Healthcare ETFs: Broad Exposure or Pharma Focus

Fool - Investing News

VanEck's concentrated 26-stock portfolio has outpaced Fidelity's broader 334-holding fund over five years, but at a steeper cost and higher volatility.

Read full article arrow
News Thumbnail
8:49 AM | Wednesday | Aug 26, 2026

How Much Do You Need Invested by 55 to Retire on Dividends at 65?

247 Wallst

Retiring at 65 on dividends sounds straightforward until you realize the number you need today at 55 depends entirely on which yield tier you trust with your financial future, and the wrong choice leaves you no runway to recover.

Read full article arrow
News Thumbnail
7:00 AM | Wednesday | Aug 26, 2026

5 Blue-Chip Dividend Stocks to Buy Before August Ends

24/7 Wall Street

August is winding down, and income-focused investors have a narrow window to line up ex-dividend dates before the calendar turns.

Read full article arrow
News Thumbnail
12:00 PM | Tuesday | Aug 25, 2026

Johnson & Johnson Is Near a Record High. Is There Still Room to Run?

24/7 Wall Street

At $270.24, Johnson & Johnson (NYSE:JNJ | JNJ Price Prediction) is a hold.

Read full article arrow
News Thumbnail
9:25 AM | Tuesday | Aug 25, 2026

“Give Me Anything But Tech”: Jim Cramer's Bold Call on the Market's Next Big Rotation

24/7 Wall Street

On CNBC's Squawk on the Street Monday morning, Jim Cramer said the tape has soured on the trade that carried the market for most of the past year.

Read full article arrow
News Thumbnail
8:02 AM | Tuesday | Aug 25, 2026

How Much Do You Really Need Invested to Replace a $120,000 Salary With Dividends?

247 Wallst

The yield you chase determines whether you need $1 million or $3.4 million, and the one that feels safest might quietly betray you a decade from now.

Read full article arrow
News Thumbnail